期刊文献+

湖北省人乳头瘤病毒基因分型检测分析 被引量:3

Analysis of Human Papillomavirus Infection and Typing in Hubei Province
下载PDF
导出
摘要 目的调查湖北省女性人群人乳头状瘤病毒(human papillomavirus,HPV)感染状况,为宫颈癌防治提供参考依据。方法收集2013年1月至2014年11月在湖北省中山医院就诊的3956例宫颈脱落细胞标本,采用PCR体外扩增和DNA反向点杂交相结合的DNA芯片技术,对宫颈脱落细胞标本进行HPV基因分型检测。结果 3956例患者中共检出HPV阳性818例,阳性率为20.68%,其中高危型HPV感染阳性率为15.77%(624/3956)。在被检测的23个HPV-DNA亚型中,最常见的依次为16型(3.72%,147/3956),52型(3.67%,145/3956),43型(3.64%,144/3956),58型(2.78%,110/3956),18型(1.49%,59/3956),33型(1.06%,42/3956),未检出MM4型。HPV阳性者中多重感染率为17.36%(142/818),以二重感染最常见(85.21%,121/142)。结论湖北省地区高危型HPV感染以HPV16、52、58、18和33比较常见,低危型HPV感染以HPV43比较常见。 Objective To investigate HPV infection status of women in Hubei province in order to provide the basis for the prevention and treatment of the cervical cancer. Methods The infection status of HPV in 3956 patients of gynecology department was examined with gene chip technique in Hubei Zhongshan hospital from 2013 January to 2014 November. Results Among the 3956 patients, 818 patients were infected with HPV (20.68%), and 624 patients were infected with HR-HPV(high risk HPV, 15.77% ). Out of the 23 subtypes of HPV, HPV-16 (3.72%, 147/3956) was the most common of all types, followed by subtypes HPV-52 (3.67% ,145/3956), HPV-43 (3.64%, 144/3956), HPV-58(2.78%, 110/3956), HPV-18(1.49%, 59/3956), HPV-33(1.06%, 42/3956), and no HPV-MM4. In the HPV positive patients, 142(17.36%, 142/818) patients were compound infected, of whom 121 ( 85.21% , 121/142) patients were super- infected. Conclusion The more common high-risk HPV subtype are HPV16, HPV52, HPV58, HPV18 and HPV33 and low-risk HPV subtype is HPV43 in Hubei province.
机构地区 湖北省中山医院
出处 《标记免疫分析与临床》 CAS 2015年第4期335-337,共3页 Labeled Immunoassays and Clinical Medicine
基金 湖北省卫生厅青年人才基金计划(QJX2012-32)
关键词 人乳头状瘤病毒 宫颈癌防治 基因分型检测 Human papillomavirus Cervical cancer prevention Gene chip technology
  • 相关文献

参考文献7

二级参考文献67

  • 1许丹,张玉泉.HPV疫苗防治宫颈癌的研究进展[J].现代妇产科进展,2007,16(2):137-139. 被引量:9
  • 2MENG YU ZHENG HAI MA YAN PIN WANG XI DAN RE FU CHUN ZHANG.Polymorphism in the upstream regulatory region of human papilloma virus type 16 from the cervical cancer biopsies in Xinjiang Uygur women[J].Journal of Microbiology and Immunology,2006,4(3):182-188. 被引量:4
  • 3Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin,2005, 55(2) :74 - 108.
  • 4Walboomers JM, Jacobs MV, Manos MM,et al. Human papillomavirus is a necessary cause of invasive cervieal cancer worldwide. J Pathol.1999, 189:12 - 19.
  • 5Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high - grade cervical lesions : a meta - analysis update. International Journal of Cancer, 2007,121 (3) :621 -632.
  • 6Ati Mahdavi, Bradley J. Vaccines Against Human Papillomavirus and Cervical Cancer: Promises and Challenges. The Oncotogist,2005,10: 528 - 538.
  • 7Subramanya D, Grivas PD. HPV and cervical cancer:updates on an established relationship. Postgrad Meal,2008,120 (4) : 7 - 13.
  • 8Carter JJ, Koutsky LA, Hughes JP, et al. Comparison of human papillomavirus types 16, 18, and 6 cap Sid antibody responses following incident infection. J Infect Dis,2000, 181:911 -919.
  • 9Wu Y, Chen Y, Li L, et al. Associations of high - risk HPV types and viral load with cervical cancer in China. J Clin Virol, 2006, 55 : 264 - 269.
  • 10Population Reference Bureau, PATH. Preventing cervical cancer worldwide. 2004. (Accessed February 28, 2006, at http://www. path. org/files/ RHprp - accp cervical_cancer_worldw, pdf. ).

共引文献213

同被引文献56

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部